Exelixis
EXEL
#1660
Rank
$13.42 B
Marketcap
$54.19
Share price
-1.94%
Change (1 day)
40.72%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company